These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3904287)

  • 1. [Possibilities for spring vaccination of schoolchildren against influenza].
    Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):95-101. PubMed ID: 3904287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventive influenza vaccination].
    Glathe H
    Z Arztl Fortbild (Jena); 1990; 84(8):377-80. PubMed ID: 2378120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 4. [The formation of an immune response in volunteers inoculated with a live recombinant influenza vaccine].
    Vorob'ev KV; Rudenko LG; Islamova IT; Grigor'eva EP; Egorov AIu; Ermachenko TA; Chepik EB; Zakharova NG; Karachentsev AM
    Vopr Virusol; 1991; 36(6):475-7. PubMed ID: 1785182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza at Lowry Air Force Base in Denver, 1982-1986.
    Meiklejohn G; Zajac RA; Evans ME
    J Infect Dis; 1987 Oct; 156(4):649-51. PubMed ID: 3624907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of adults to sequential influenza vaccination.
    Powers RD; Hayden FG; Samuelson J; Gwaltney JM
    J Med Virol; 1984; 14(2):169-75. PubMed ID: 6491643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
    Mitchell DK; Ruben FL; Gravenstein S
    Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza vaccine for 2018-2019.
    Med Lett Drugs Ther; 2018 Oct; 60(1558):169-173. PubMed ID: 30335044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basic results of a committee trial of the new vaccine Grippovac SE-AZh].
    Bashliaeva ZA; Sumarokov AA; Nefedova LA; Iaroshevskaia IIu; Ozeretskovskaia NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):49-54. PubMed ID: 3515812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccination in dialysis and transplant patients.
    Versluis DJ; Beyer WE; Masurel N; Weimar W
    Antiviral Res; 1985; Suppl 1():289-92. PubMed ID: 3909959
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of state trials of inactivated influenza vaccines for children].
    Vasil'eva RI; Smirnova LA; Rudenko LG; Drinevskiĭ VP; Tsaritsina IM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):49-54. PubMed ID: 2968738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    Rudraraju R; Mordant F; Subbarao K
    J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
    [No Abstract]   [Full Text] [Related]  

  • 17. [The quadrivalent vaccines against seasonal influenza. Are the ultimate solution?].
    Reina J
    Med Clin (Barc); 2014 Apr; 142(8):355-7. PubMed ID: 24581840
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza vaccination with adjuvant RU41740 in the elderly.
    Profeta ML; Guidi G; Meroni PL; Palmieri R; Palladino G; Cantone V; Zanussi C
    Lancet; 1987 Apr; 1(8539):973. PubMed ID: 2882355
    [No Abstract]   [Full Text] [Related]  

  • 19. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 20. Influenza vaccine for 2016-2017.
    Med Lett Drugs Ther; 2016 Oct; 58(1505):127-130. PubMed ID: 27701363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.